|
1
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tannapfel A, Neid M, Aust D and Baretton
G: The origins of colorectal carcinoma: Specific nomenclature for
different pathways and precursor lesions. Dtsch Arztebl Int.
107:760–766. 2010.PubMed/NCBI
|
|
4
|
Jass JR: Gastrointestinal polyposes:
Clinical, pathological and molecular features. Gastroenterol Clin
North Am. 36:927–946. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Printz C: Colorectal cancer incidence
increasing in young adults. Cancer. 121:1912–1913. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Krishnamurthy A, Kankesan J, Wei X, Nanji
S, Biagi JJ and Booth CM: Chemotherapy delivery for resected
colorectal cancer liver metastases: Management and outcomes in
routine clinical practice. Eur J Surg Oncol. 43:364–371. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yates LR and Campbell PJ: Evolution of the
cancer genome. Nat Rev Genet. 13:795–806. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Meyerson M, Gabriel S and Getz G: Advances
in understanding cancer genomes through second-generation
sequencing. Nat Rev Genet. 11:685–696. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chaleshi V, Haghighi MM, Savabkar S, Zali
N, Vahedi M, Khanyaghma M, Javadi GR, Asadzade H and Zali MR:
Correlation between the EGF gene intronic polymorphism, rs2298979,
and colorectal cancer. Oncol Lett. 6:1079–1083. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu X, Sood AK, Dang CV and Zhang L: The
role of long noncoding RNAs in cancer: The dark matter matters.
Curr Opin Genet Dev. 48:8–15. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rafiee A, Riazi-Rad F, Havaskary M and
Nuri F: Long noncoding RNAs: Regulation, function and cancer.
Biotechnol Genet Eng Rev. 34:153–180. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Y, Egranov SD, Yang L and Lin C:
Molecular mechanisms of long noncoding RNAs-mediated cancer
metastasis. Genes Chromosomes Cancer. 58:200–207. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li XL, Zhou J, Chen ZR and Chng WJ: P53
mutations in colorectal cancer - molecular pathogenesis and
pharmacological reactivation. World J Gastroenterol. 21:84–93.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang A, Xu M and Mo Y-Y: Role of the
lncRNA-p53 regulatory network in cancer. J Mol Cell Biol.
6:181–191. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chaudhary R and Lal A: Long noncoding RNAs
in the p53 network. Wiley Interdiscip Rev RNA. 8:e14102017.
View Article : Google Scholar
|
|
16
|
Tripathi V, Shen Z, Chakraborty A, Giri S,
Freier SM, Wu X, Zhang Y, Gorospe M, Prasanth SG, Lal A and
Prasanth KV: Long noncoding RNA MALAT1 controls cell cycle
progression by regulating the expression of oncogenic transcription
factor B-MYB. PLoS Genet. 9:e10033682013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang A, Zhou N, Huang J, Liu Q, Fukuda K,
Ma D, Lu Z, Bai C, Watabe K and Mo YY: The human long non-coding
RNA-RoR is a p53 repressor in response to DNA damage. Cell Res.
23:340–350. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen S, Liang H, Yang H, Zhou K, Xu L, Liu
J, Lai B, Song L, Luo H, Peng J, et al: LincRNa-p21: Function and
mechanism in cancer. Med Oncol. 34:982017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM Classification of Malignant Tumours. 7th. Wiley-Blackwell;
New Jersey, NY: 2011
|
|
20
|
Kheirelseid EA, Chang KH, Newell J, Kerin
MJ and Miller N: Identification of endogenous control genes for
normalisation of real-time quantitative PCR data in colorectal
cancer. BMC Mol Biol. 11:122010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2− ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vatandoost N, Ghanbari J, Mojaver M, Avan
A, Ghayour-Mobarhan M, Nedaeinia R and Salehi R: Early detection of
colorectal cancer: From conventional methods to novel biomarkers. J
Cancer Res Clin Oncol. 142:341–351. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Edwards BK, Ward E, Kohler BA, Eheman C,
Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I,
Seeff LC, et al: Annual report to the nation on the status of
cancer, 1975–2006, featuring colorectal cancer trends and impact of
interventions (risk factors, screening, and treatment) to reduce
future rates. Cancer. 116:544–573. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xie X, Tang B, Xiao Y-F, Xie R, Li BS,
Dong H, Zhou JY and Yang SM: Long non-coding RNAs in colorectal
cancer. Oncotarget. 7:5226–5239. 2016.PubMed/NCBI
|
|
25
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: Functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Luo J, Qu J, Wu D-K, Lu Z-L, Sun Y-S and
Qu Q: Long non-coding RNAs: A rising biotarget in colorectal
cancer. Oncotarget. 8:22187–22202. 2017.PubMed/NCBI
|
|
27
|
Yamada A, Yu P, Lin W, Okugawa Y, Boland
CR and Goel A: A RNA-Sequencing approach for the identification of
novel long non-coding RNA biomarkers in colorectal cancer. Sci Rep.
8:5752018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang P, Yang Y, An W, Xu J, Zhang G, Jie J
and Zhang Q: The long noncoding RNA-ROR promotes the resistance of
radiotherapy for human colorectal cancer cells by targeting the
p53/miR-145 pathway. J Gastroenterol Hepatol. 32:837–845. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin β4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun D, Li X, He Y, Li W, Wang Y, Wang H,
Jiang S and Xin Y: YAP1 enhances cell proliferation, migration, and
invasion of gastric cancer in vitro and in vivo. Oncotarget.
7:81062–81076. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Konishi H, Ichikawa D, Yamamoto Y, Arita
T, Shoda K, Hiramoto H, Hamada J, Itoh H, Fujita Y, Komatsu S, et
al: Plasma level of metastasis-associated lung adenocarcinoma
transcript 1 is associated with liver damage and predicts
development of hepatocellular carcinoma. Cancer Sci. 107:149–154.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gellad ZF and Provenzale D: Colorectal
cancer: National and international perspective on the burden of
disease and public health impact. Gastroenterology. 138:2177–2190.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu Y, Lu W, Xu J, Shi Y, Zhang H and Xia
D: Prognostic value of long non-coding RNA MALAT1 in cancer
patients. Tumour Biol. 37:897–903. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dong Y, Liang G, Yuan B, Yang C, Gao R and
Zhou X: MALAT1 promotes the proliferation and metastasis of
osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol.
36:1477–1486. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen Y, Wei G, Xia H, Yu H, Tang Q and Bi
F: Down regulation of lincRNA-p21 contributes to gastric cancer
development through Hippo-independent activation of YAP.
Oncotarget. 8:63813–63824. 2017.PubMed/NCBI
|
|
36
|
Wang X, Xu Y, Wang X, Jiang C, Han S, Dong
K, Shen M and Xu D: LincRNA-p21 suppresses development of human
prostate cancer through inhibition of PKM 2. Cell Prolif.
50:e123952017. View Article : Google Scholar
|
|
37
|
Tang SS, Zheng BY and Xiong XD:
LincRNA-p21: Implications in human diseases. Int J Mol Sci.
16:18732–18740. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
De Paepe B, Lefever S and Mestdagh P: How
long noncoding RNAs enforce their will on mitochondrial activity:
Regulation of mitochondrial respiration, reactive oxygen species
production, apoptosis, and metabolic reprogramming in cancer. Curr
Genet. 64:163–172. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang G, Li Z, Zhao Q, Zhu Y, Zhao C, Li X,
Ma Z, Li X and Zhang Y: LincRNA-p21 enhances the sensitivity of
radiotherapy for human colorectal cancer by targeting the
Wnt/β-catenin signaling pathway. Oncol Rep. 31:1839–1845. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhao W, Song M, Zhang J, Kuerban M and
Wang H: Combined identification of long non-coding RNA CCAT1 and
HOTAIR in serum as an effective screening for colorectal carcinoma.
Int J Clin Exp Pathol. 8:14131–14140. 2015.PubMed/NCBI
|
